Table A5.
Descriptive statistics of acrylamide biomarker levels per study (smoker).
Study | Pop | Sype | Mean | Sd | Geom. Mean | Min | Max | Median | q10 | q25 | q75 | q90 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PT-INSEF | 72 | AAMA-crt | 168.58 | 119.23 | 135.92 | 26.38 | 675.61 | 140.08 | 56.39 | 93.83 | 217.21 | 299.83 |
PT-INSEF | 72 | AAMA | 228.03 | 187.44 | 164.47 | 29.3 | 893.75 | 175.18 | 47.36 | 95.81 | 293.13 | 498.81 |
PT-INSEF | 71 | GAMA-crt | 40.87 | 21.73 | 36.91 | 13.09 | 148 | 37.17 | 22.53 | 28.08 | 44.33 | 63.78 |
PT-INSEF | 71 | GAMA | 52.04 | 30.52 | 44.22 | 13.55 | 170.69 | 43.53 | 19.71 | 29.46 | 66.36 | 92.78 |
PT-INSEF | 72 | AGE | 34.11 | 2.96 | 33.98 | 28 | 39 | 34 | 30 | 32 | 36 | 38 |
FR-ESTEBAN | 102 | AAMA-crt | 302.29 | 302.67 | 218.98 | 22.98 | 2346.83 | 217.83 | 81.12 | 131.47 | 367.95 | 565.61 |
FR-ESTEBAN | 102 | AAMA | 288.69 | 202.08 | 225.61 | 39.78 | 959.76 | 227.42 | 81.44 | 143 | 396.5 | 548.49 |
FR-ESTEBAN | 102 | GAMA-crt | 29.79 | 30.68 | 22.32 | 3.25 | 250.68 | 21.7 | 9.8 | 13.99 | 34.46 | 51.66 |
FR-ESTEBAN | 102 | GAMA | 27.62 | 16.66 | 23 | 5.63 | 115.89 | 25.63 | 9.36 | 14.42 | 38.28 | 47.58 |
FR-ESTEBAN | 102 | AGE | 32.38 | 4.78 | 32.01 | 20 | 39 | 33 | 26 | 29 | 36 | 38 |